Senate Confirms Dr. Erica Schwartz as CDC Director

The United States Senate has confirmed Dr. Erica Schwartz as the new director of the Centers for Disease Control and Prevention (CDC), the federal agency tasked with protecting public health. The vote was 51-44, according to multiple reports.

Schwartz, 54, is the first permanent CDC director since Susan Monarez, who was fired last year by Health Secretary Robert F. Kennedy Jr. after less than a month in the role over a dispute regarding vaccine policy. Schwartz is President Donald Trump's third nominee for the position, a fact noted by all three outlets that covered the confirmation.

Her confirmation marks a rare win for the Trump administration, which has faced repeated failures in filling senior health posts. Al Jazeera reported that Schwartz's confirmation had been in doubt as lawmakers questioned whether she would operate the agency based on scientific information or the demands of the president. During a Senate committee hearing last month, Republican Bill Cassidy questioned whether Schwartz would remain firm under pressure from the administration; he later stated he had gained confidence in her after speaking with her.

Schwartz brings a background as a board-certified preventive medicine physician, a role as the US Coast Guard's chief medical officer from 2015 to 2019, and service as deputy surgeon general during Trump's first term. She holds a medical degree from Brown University and a law degree, as reported by the Jerusalem Post.

Coverage Comparison

The three news outlets that covered this story — Al Jazeera, The Guardian, and the Jerusalem Post — were broadly aligned on the core facts: the 51-44 vote, Schwartz's status as Trump's third nominee, and her becoming the first permanent director since Monarez. Where they diverged was in framing and detail.

Al Jazeera emphasized the turmoil at the CDC, describing the agency as struggling with low morale and mass resignations since Trump returned to office. The outlet quoted Dr. Georges Benjamin of the American Public Health Association, who said in a statement: "With all the turmoil of the past two years, the CDC desperately needs stability, experienced leadership and a steadfast commitment to science."

The Guardian reported the confirmation more neutrally, noting the "tumultuous period of leadership turnover" at the CDC and the administration's failed attempts to fill health posts. It mentioned that the first nominee, former Florida congressman David Weldon, was withdrawn in March 2025 just before his confirmation hearing.

The Jerusalem Post provided additional context about the challenges facing the new director, including the worst US measles resurgence in three decades, an international Ebola outbreak in the Democratic Republic of the Congo and Uganda, and the largest US foodborne illness outbreak in recent years.

Key Claims

  • Dr. Erica Schwartz was confirmed by the US Senate as director of the CDC in a 51-44 vote, as reported by all three outlets.
  • Schwartz is Trump's third nominee for the position; his first pick, David Weldon, withdrew, and his second, Susan Monarez, was fired after less than a month.
  • The CDC has faced a period of leadership turnover and internal challenges. Al Jazeera reported that layoffs and resignations have resulted in the loss of about 3,000 workers, many of whom expressed frustration with vaccine policies promoted by Health and Human Services Secretary Robert F. Kennedy Jr.
  • Schwartz's background includes serving as deputy surgeon general under Trump, chief medical officer of the US Coast Guard, and holding both medical and law degrees, as detailed by the Jerusalem Post.
  • The Jerusalem Post reported that Schwartz inherits an agency confronting the worst US measles resurgence in three decades and an international Ebola outbreak in the Democratic Republic of the Congo and Uganda.
As the new director takes office, public health experts have expressed cautious optimism, but the road ahead is fraught with challenges. The CDC's stability and its commitment to science will be closely watched, according to experts quoted by Al Jazeera.